Background: MiRNAs are small, noncoding RNAs possessing the potential to modulate gene
INTRODUCTION
MicroRNAs (miRNAs) are approximately 22 nucleotide endogenous RNA molecules which have the potential to regulate gene expression by binding messenger RNA (mRNA) and inducing translational repression or mRNA degradation (Hauberg et al., 2016) . miRNAs have been implicated in early development, proliferation apoptosis, metabolism and cell differentiation (Hunsberger et al., 2009) . miRNAs have also been associated with risk for a number of mental disorders including schizophrenia, bipolar disorder and depression (Hunsberger et al., 2009; Meydan et al., 2016) .
To date, little work has focused on the role of miRNAs in obsessive-compulsive disorder (Kandemir et al., 2015; Mattheisen et al., 2015; Privitera et al., 2015) . It has been speculated that miRNAs may be involved in OCD pathogenesis, and may serve as potential treatment targets (Review: Issler and Chen 2015), but to date no empirical data exists to support this conclusion. Nevertheless, given the established roles for miRNA in anxiety-related disorders, this is a reasonable avenue to pursue (Chao and Chen 2013) . In other conditions, peripheral miRNA-based biomarkers have already been shown to have even greater prognostic significance than mRNAs (Nair et al., 2012) .
Summary statistics from the Psychiatric Genomics Consortium (PGC) have previously been employed to study miRNA-related targets in schizophrenia (Hauberg et al., 2016) . Considering the clinical, genetic and comorbid overlap of OCD with schizophrenia (Cederlöf et al., 2015) this study aims to investigate the most significant findings from the TS/OCD PGC workgroup Variants presenting with p-values of 1 x 10 -4 or lower were prioritized from this summary statistics data (n = 240). The prioritized variants were investigated for miRNA-related gene regulation as predicted by miRBASE (www.mirbase.org; (Ambros et al., 2003) ), TargetScan (www.targetscan.org; (Agarwal et al., 2015) ) and SNPnexus (www.snp-nexus.org; (Chelala et al., 2009) ). Similarly, these prioritised variants were stratified into increased risk (n = 28) and decreased risk (n = 36), by requiring uniform directionality across each of the seven independent data sets included in the OCD meta-analysis, and investigated for miRNA-related gene regulation.
Host genes for the 240 prioritised single nucleotide polymorphisms (SNPs) (using SNPnexus)
were subjected to enrichment analyses using Enrichr (http://amp.pharm.mssm.edu/Enrichr; (Chen et al., 2013) ). Host genes for SNPs associated with consistently increased (n = 28), or consistently decreased (n = 36) risk for an OCD diagnosis were also investigated via Enrichr (Chen et al., 2013) . Enrichr utilises 35 gene-set libraries across six categories (transcription, pathways, ontologies, diseases/ drugs, cell types and miscellaneous) to compute enrichment.
Enrichment is calculated using Fishers' exact test assuming a binomial distribution and independence for probability of any gene belonging to any set. Corrected p-values are calculated by computing a Z-score statistic, i.e. the mean rank and standard deviation from each computed rank calculated for each term in a gene-set library where the Z-score represents the deviation from this expected rank (described by (Chen et al., 2013) . The most accurate statistical representation is defined by the combined score, which is a representation of the Fischer exact and Z-score statistics (Chen et al., 2013) . Correction for multiple testing was accounted for using the Benjamini-Hochberg method (Benjamini and Hochberg, 1995) .
Prioritized SNP host genes were further investigated for potential miRNA-regulated involvement using SNPnexus, independent of GWAS-identified SNPs
RESULTS

OCD Summary Statistics
Prioritisation of the OCD summary statistics yielded 240 SNPs which presented with a GWAS significance of 1 x 10 -4 or lower (Supplementary Table 1 ). Of the 240 variants identified, 28 risk alleles (A1 , Tables 1 and 2) were consistently associated with increased susceptibility risk, and 36 (A1 , Tables 1 and 2 ) with decreased susceptibility risk, for an OCD diagnosis (Tables   1 and 2 , respectively).
miRNA-associated regulatory analyses
Of the 240 prioritised SNPs, none presented with direct potential miRNA-mediated regulation potential when investigated using miRBase, TargetScan and SNPnexus.
Genetic Association of Complex Diseases and Disorders (GAD)
Investigation of the prioritized variant host genes (n = 58) using SNPnexus yielded GAD disease class and phenotype affiliations (Supplementary Table 2 ). This analysis was repeated for polymorphisms associated with either increased (Table 3) or decreased (Table 4) susceptibility risk for an OCD diagnosis.
Enrichment analyses
Enrichment analyses was performed using the Enrichr online bioinformatic tool. Tables 5 and 6 , respectively.
miRNA-regulated mediation of OCD
Although no direct miRNA-mediated SNP-related hits were identified, the prioritized variant host genes provided by SNPnexus were investigated for miRNA-related enrichment analyses.
This was performed for all 58 host genes described above (Supplementary Table 4 ) and the sub-prioritised increased (Table 7) and decreased (Table 8 ) susceptibility risk genes. These host genes were predicted to be regulated by a number of miRNA transcripts, independent of GWAS-prioritized SNPs.
Unique miRNA transcripts
Considering the list of miRNA transcripts identified ( (GPR109A), and mir-219 and mir-98 which target Cingulin-like 1 (CGNL1).
DISCUSSION
This study identified four novel miRNAs and three novel candidate genes associated with susceptibility risk to OCD. Although direct links between significant GWAS variants and miRNAs have been previously described in literature (Hauberg et al., 2016) , no direct links were identified in this study.
Most significant OCD summary statistics hits not directly associated with miRNAs
The original OCD genome-wide meta-analysis from which this study derives identified no was not surprising, as no GWAS study to date has revealed associations surpassing genomewide significance threshold levels (Mattheisen et al., 2015; Stewart et al., 2013) in OCD, almost certainly due to insufficient sample sizes. Due to the common-variant-small-effect-size hypothesis for OCD (Visscher et al., 2012) , as well as clear confounding environmental factors (Hemmings et al., 2013; McGregor et al., 2016) , a fourth-tier significance threshold (p ≤ 1 x 10 -4 ) was adopted and all variants meeting this criterion was investigated for miRNAmediated regulatory roles in OCD pathogenicity.
Two-hundred and forty SNPs survived this inclusion criterion, however, as previously mentioned none of them directly implicated miRNA-regulatory effects either by known miRNA binding sites, miRNA expression or within miRNA constructs themselves (as predicted by the in silico bioinformatics tools previously described) In silico bioinformatic analyses of these 240 variants revealed that although these GWAS SNPs were not directly involved, the genes wherein they were located had miRNA-mediated regulatory potential (i.e. produced or were targeted by miRNAs). Enrichment analyses of these genes for biological processes revealed the most significant hits to be associated with oxidative stress, immune response and metabolic processes. Oxidative stress and inflammatory roles have been noted to play a role in psychiatric disorders (Attwells et al., 2017; Emsley et al., 2015; Gonçalves et al., 2017; Mitchell and Goldstein, 2014) .. The results presented here support these hypotheses and warrant more thorough investigation of inflammatory markers and pathways in the molecular aetiology of OCD and anxiety-related disorders.
Enrichment analyses identifies miRNAs potentially involved in OCD psychopathology
In order to identify specific miRNA transcripts associated with increased or decreased risk for OCD, candidate genes identified from the prioritised GWAS SNPs were investigated for predicted miRNA-mediated regulation (Tables 7 and 8 ). Four miRNA transcripts (mir-520A, mir-525, mir-219 and mir-98) were found to be unique to increased risk for OCD and one miRNA transcript (mir-124A) for decreased risk for OCD. Further investigation of these transcripts revealed three candidate miRNA-mediated regulatory genes. Considering increased risk for OCD, mir-219 and mir-98 have the same recognition sequence and target CGNL1 and GPR109A, implicating that miRNA-mediated regulation of CGNL1 and CPR109A may be implicated in increased susceptibility for OCD. Parallel to this, mir-124A-mediated regulation of ITPR3 expression could be protective against an OCD diagnosis.
Increased risk for OCD
Both CGNL1 and GPR109A were identified as potential regulatory targets associated with increased risk for OCD. CGNL1 is found at adherent and tight cell-cell junctions and coordinates junction assembly (Citi et al., 2012; Rees et al., 2014; van de Vondervoort et al., 2016) . Little is known about the role of CGNL1 in human disease (Citi et al., 2012) . CGNL1, however, has been linked to another junctional protein i.e. PLEKHA7 (Citi et al., 2012) , and this protein has been linked to cardiac contractility and morphogenesis through mechanisms involving intracellular Ca 2+ handling (Wythe et al., 2011) . Furthermore, CGNL1 has been studied in relation G-coupled exchange factors whereby it has been associated with the finetuning of Rho family GTPases during junction assembly as well as confluence (Aijaz et al., 2005; Citi et al., 2012) .
GPR109A codes for a G-protein coupled receptor for nicotinic acid (niacin) (Soga et al., 2003; Wise et al., 2003) . The most relevant association of this gene with the psychopathology relates to niacin's role in the attenuation of neuroinflamation, and has previously been suggested as a therapeutic target for neuroimmune disorders (Offermanns and Schwaninger, 2015; Wakade and Chong, 2014) . The role of niacin in inflammation is unclear, but it has been reported that the effects of niacin are mediated by GPR109A, which is found to be highly expressed in adipose tissue and macrophage cells (Feingold et al., 2014) . Feingold and colleagues have demonstrated that immune activation increased expression of GPR109A by between 3-and 5-fold.
In summary, relatively little is known about the role of GPR109A and CGNL1 in immune dysregulation and Ca 2+ homeostasis, and we can only speculate their potential contribution to the pathogenesis of OCD. Nevertheless, these findings are consistent with growing evidence that immune dysregulation and Ca 2+ homeostasis may play a role in the pathogenesis of a number of psychiatric disorders (Citi et al., 2012; Feingold et al., 2014; Haughey et al., 1999; Santulli and R. Marks, 2015; Wythe et al., 2011; Zündorf and Reiser, 2010) and further work within this area may prove paramount to uncovering mechanisms underlying the psychopathology of OCD.
Decreased risk for OCD
The ITPR3 gene encodes for a second messenger that mediates the release of intracellular calcium in muscle and brain tissues (Santulli and R. Marks, 2015) . Dysregulation of the intracellular calcium homeostasis has been implicated in aberrant cardiac contraction, synaptic transmission and cellular metabolism (Santulli and R. Marks, 2015) . Calcium dysregulation plays a role in oxidative stress, inflammation and neuronal degradation (Zündorf and Reiser, 2010) and calcium channel genes have been repeatedly identified in psychiatric-based GWAS studies (Avramopoulos et al., 2015; Bergen et al., 2012; Curtis et al., 2011; Wang et al., 2012) .
Furthermore, inbred animal models with mutant Itpr3 genes have been reported to exhibit aberrant behaviours resembling social deficits, anxiety, and general behavioural inflexibility (Av et al., 2016) . Considering the mir-124A transcript, it has previously been implicated in pro-inflammatory regulation independently of ITPR3 involvement, where it has been shown to negatively regulate inflammation and myeloid cell proliferation (Manoharan et al., 2014) . The literature suggests a role for mir-124A-mediated regulation and ITPR3-related dysregulation contributing to altered intracellular calcium homeostasis and pro-inflammatory responses.
These irregular mechanisms have previously been reported to be associated with oxidative stress, Ca 2+ -dependent synaptic dysfunction, impaired plasticity and neuronal demise (Haughey et al., 1999; Zündorf and Reiser, 2010) . Neither mir-124A, nor ITPR3 have previously been associated with the molecular aetiology or psychopathology of OCD, and therefore present as novel findings in this study, and are strongly supported by literature.
Limitations
Although miRNA transcripts and genes were identified as potential candidates for miRNAmediated involvement in the psychopathology of OCD it is important to note that the sample size represented here, although seemingly large, is still relatively small considering GWAS in other psychiatric disorders (Hauberg et al., 2016) . The generally accepted hypothesis of a number of rare and common variants collectively contributing small effect sizes to the clinical manifestation of disease means that much larger sample sizes are required to surpass significance thresholds (Manolio et al., 2009) . This is spoken too by the fact that none of the miRNA transcripts identified reached significance thresholds after adjusting for multiple testing. That said we believe the work presented here does point to plausible candidates for future considerations based on the role these gene targets play in synaptic modelling and remodelling.
Conclusion
This study presents novel candidate miRNA and gene targets for susceptibility risk to OCD.
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